Transcription of ORAL DRUG DELIVERY
{{id}} {{{paragraph}}}
drug DELIVERY : FORMULATION SELECTION METHODS & NOVEL DELIVERY TECHNOLOGIESOUTSTANDING ISSUE SPONSOR2 CONTENTSThe views and opinions expressed in this issue are those of the authors. Due care has been used in producing this publication, but the publisher makes no claim that it is free of error. Nor does the publisher accept liability for the consequences of any decision or action taken (or not taken) as a result of any information contained in this cover image: Multiple chrome pills , Photo Longer a Hit-or-Miss Proposition: Once-Daily Formulation for Drugs with pH-Dependent SolubilityGopi Venkatesh, Director of R&D & Anthony Recupero, Senior Director, Business DevelopmentAptalis Pharmaceutical Technologies 4-8A possible approach for the desire to innovateBrian Wang, CEO & Dr Junsang Park, CSOGL PharmTech 10-13 COMPANY PROFILE - Mayne Pharma International 14-15 From Powder to Pill.
www.ondrugdelivery.com oral drug delivery: formulation selection methods & novel delivery technologies outstanding issue sponsor
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
NEW ZEALAND DATA SHEET, Enteric coated, Development of mesalazine pellets coated, Review of the FDA Dissolution Methods, Development, Dosage Form Design: Pharmaceutical and, Controlled-Release Capsule Formulation: Challenges and Solutions, Q5C Stability testing of Biotechnological /, Q5C - Stability testing of Biotechnological / Biological, Monocytosis